All News | FDA

Advertising & Promotion

Jul 8, 2014
Gilead Sciences Slapped With Untitled Letter for Sponsored Link
Jul 2, 2014
House Bill Would Ban E-cigarette Marketing to Children
Jun 21, 2014
FDA Draft Guidance: When Correcting Third-Party Misinformation Online, Don’t Cherry Pick Corrections
Jun 18, 2014
Draft Guidance on Space-limited Promotion Makes No Allowance for Shortcuts on Risk Information
Jun 16, 2014
High Court: Companies Can Sue Over FDA-approved Advertising
Jun 16, 2014
Fourth Untitled Letter in a Row Tackles Missing Risk Information
Jun 10, 2014
Supplement Marketers Settle FTC Claims of Deceptive Advertising
Jun 9, 2014
GSK Settles Off-label Claims With 44 States for $105 Million
Jun 2, 2014
Promotion Limits Untouched in Expedited Approval Guidance
May 27, 2014
Eye-tracking Study on Distractions in TV Ads Off to OMB for Approval

Good Clinical Practice

Mar 28, 2016
Researchers Find Limited Interest in Available Individual Subject Data
Mar 25, 2016
Recruitment Begins for ASCO’s First Clinical Trial
Mar 25, 2016
Idaho, W.Va. Governors Sign ‘Right-to-Try’ Laws
Mar 24, 2016
23andMe Offers ResearchKit Module
Mar 24, 2016
Minnesota House Considers Bills To Strengthen University IRB’s Oversight and Ombudsman’s Role
Mar 24, 2016
Maine House Passes ‘Right-to-Try’ Bill
Mar 21, 2016
Research Institute Will Pay $3.9 Million in HIPAA Settlement, Undertake Corrective Action
Mar 19, 2016
FDA-NIH Develop Protocol Template for NIH Funded Phase 2 or 3 IND and IDE Trials
Mar 17, 2016
FDA Debars Former Study Coordinator
Mar 17, 2016
Miss. House Considers Tort Immunity for Hospitals, Insurers in ‘Right-to-Try’ Cases

FDA Regulation & Enforcement

Dec 19, 2018
San Francisco Sues Opioid Makers Over Sales Practices
Dec 18, 2018
Gottlieb Says New Policies May Be Coming To Improve Supplement Oversight
Dec 17, 2018
WLF Calls on CMS To Withdraw Proposed Rule Mandating Price Disclosure in Drug DTC TV Ads
Dec 17, 2018
FDA Withdraws Proposed Rule That Would Have Allowed Unilateral Changes to Generic Drug Labeling
Dec 17, 2018
Olympus Medical Systems, Former Top Regulatory Official Plead Guilty to Medical Device Report Violations
Dec 14, 2018
KOLs Find Reasons for Negative Results
Dec 14, 2018
NAD Recommends Two Supplement Makers Discontinue Sun Protection Claims
Dec 14, 2018
NAD Refers Laser Device Claims to FTC, FDA
Dec 13, 2018
Alaskan Natives Sue Companies Over Marketing of Opioid Products
Dec 13, 2018
Four Ad Promotion Questions for 2019

Copyright © Thompson FDA, a division of CBIS. All rights reserved.